New test promises quicker, more accurate evaluation for cystic fibrosis patients

Researchers at National Jewish Health have identified a simple gene-based blood test that more accurately and quickly measures cystic fibrosis patients' response to therapy than current tests. The test, a measure of inflammatory gene expression, could improve patient care and help clear a backlog of promising medications now hung up in clinical trials. The researchers recently published the results of a small "proof-of-principal" trial in the online version of American Journal of Respiratory and Critical Care Medicine, and will also publish them in a future print issue.

Read the whole article on Physorg

More from Physorg